Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Global IVD Market to be Worth US$ 52 Billion by 2013

Mar 29, 2011
Share |
 
The global IVD industry has been witnessing sharp growth patterns for the past few years on the back of factors, such as shifts towards more complex immunochemistry tests to Point of Care (PoC) testing, new technological advancements, and the adoption of cost-cutting measures. The market size of global IVD market was estimated at US$ 44 Billion in 2010, up by 5% compared to 2009. The market will experience positive developments in technology and innovation in future. Fuelled by strong market drivers, the global IVD market is likely to reach around US$ 52 Billion by 2013 says our new research report Global In Vitro Diagnostic Market Analysis”.
 
Currently, the global IVD market is dominated by regions, such as North America, Europe, and Japan, which collectively occupy around 80% share of the total market. In North America, United States has the largest share, which is also a largest IVD market in world. Germany accounts for a 21% share of the total market in Europe, followed by France and Italy. Japan is the world’s third-largest IVD market, with an estimated 309 Billion Yen size in 2009.
 
The report Global In Vitro Diagnostic Market Analysisdivides the overall IVD market into key segments and provides all the important statistic and developments. The report also covers a description regarding key market drivers, which have been boosting the market potential and will provide a growth momentum in future. The current scenario and future projection of IVD market in key indications have also been provided. Diseases, such as diabetes, cancer, HIV, tuberculosis, and cardiovascular have been analyzed in an effective manner in this regard.
 
The report is an outcome of an extensive research and prudent analysis of the global IVD market that properly identifies the recent industry developments and analyzes their impact on market performance. The forecast in key areas of the report makes use of effective methods and techniques that seek to present a realistic view of the future outlook. Last though not the least, a proper coverage of key market players and their recent activities complete the overall industry analysis.

For more information visit: http://www.rncos.com/Report/IM103.htm

Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports